相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints
E. M. M. Quigley et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
An evaluation of the FDA Responder Endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials
J. E. Macdougall et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis
Jan Tack et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2013)
Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation
Maura Corsetti et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2013)
Linaclotide: Promising IBS-C Efficacy in an Era of Provisional Study Endpoints
Gregory S. Sayuk
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
Satish Rao et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials
B. M. R. Spiegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Adequate Relief in a Treatment Trial With IBS Patients: A Prospective Assessment
Maria C. F. Passos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Psychometric Evaluation of Patient-Reported Outcomes in Irritable Bowel Syndrome Randomized Controlled Trials: A Rome Foundation Report
Brennan Spiegel et al.
GASTROENTEROLOGY (2009)
Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
J. Tack et al.
GUT (2009)
Effects of 5-hydroxytryptamine (serotonin) type 3 antagoniosts on symptom relief and constipation in nonconstipated irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
Viola Andresen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Primary endpoints for irritable bowel syndrome trials: A review of performance of endpoints
Michael Camilleri et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation
J Tack et al.
GUT (2005)
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
DC Turk et al.
PAIN (2003)
Treatment of irritable bowel syndrome: a review of randomised controlled trials
R Akehurst et al.
GUT (2001)
分享论文
